What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm Saturday 9am - 5pm Sunday 9am - 5pm

CenExel

CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV clinical trials.

Our attention to detail assures quality results that both sponsors and patients can trust.

The CenExel Centers of Excellence clinical research network includes ACMR, ACT, AMRI, CBH, CIT, CNR, FCR, JBR, RMCR, RCA, iResearch (locations below). Our Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV first-in-human cl

inical trials. All of our Centers of Excellence have highly experienced Principal Investigator physicians and research staff serving the following indications; Sleep, Pain Management, Dermatology, Movement Disorders, CNS, Vaccines, Womens Services, and Ethnic-Bridging. Our attention to detail assures quality results that both patients and sponsors can trust, which is evident in the consistency that we achieve and exceed our patient recruitment goals. Our patients' wellness and safety are at the heart of every decision we make. We value our sponsor and CRO relationships and are optimistic about the work we will do together in the future as partners. To speak to our business development team email:
[email protected]. Visit us at cenexelresearch.com for more information. Where are we located? CenExel HQ: Salt Lake City, UT
ACMR, Atlanta, GA
ACT, Anaheim, CA
AMRI, Toms River, NJ
CBH, Gaithersburg, MD
CIT, Anaheim, CA
CNR, Sherman Oaks, CA
FCR, Tampa, FL
IResearch, Atlanta/Savannah
JBR, SLC, UT
RCA, Hollywood, FL
RMCR, Englewood, CO

09/07/2026

Obesity is a chronic disease, not simply a number on the scale.

Our Principal Investigator, Dr. Saundra Maass-Robinson, explains why obesity requires ongoing chronic disease management and why researchers are examining more than pounds lost or changes in waist circumference.

Clinical trials are also evaluating broader measures of health, including blood pressure, lipids, inflammation markers, and cardiovascular indicators.

Dr. Maass-Robinson also references findings from separate semaglutide and tirzepatide trials. Because these were not head-to-head studies, their results should not be interpreted as a direct comparison.

For patients, research participants, sponsors, CROs, and investigators, these broader outcomes can provide a more complete picture of metabolic health.

Interested in participating in clinical research? Explore current study opportunities at https://cenexelclinicaltrials.com/.

For educational purposes only. This content is not medical advice.

09/04/2026

Great study outcomes begin with great people!

CenExel’s experienced, dedicated teams bring deep therapeutic expertise, rapid start-up capabilities, and flexible ex*****on to every study. We collaborate closely with sponsors and CROs to navigate challenges, create solutions, and keep progress moving.

More than a site. A partner in your success.

Rescue today. Results tomorrow. Let’s get your study back on course.

🔗 Meet the capabilities behind our experienced teams by clicking the link in our bio.

09/03/2026

What if the next chapter of GLP-1 therapies goes far beyond weight loss?

In this Reel, our Principal Investigator, Dr. Saundra Maass-Robinson, discusses the field’s evolution from appetite control and weight loss toward broader metabolic health, systemic protection, and precision medicine.

For patients and families affected by metabolic conditions, continued clinical research may help uncover new approaches focused not only on losing weight, but also on improving overall health. The people who participate in clinical trials play an essential role in helping researchers evaluate the safety and potential benefits of investigational treatments.

Interested in participating in clinical research? Explore current study opportunities at https://cenexelclinicaltrials.com/.

Sponsors and CROs can learn more about CenExel’s clinical research network at https://cenexelresearch.com/.

09/02/2026

Momentum matters, and the right partner can help you find it. ⏱️

CenExel combines experienced teams with established recruitment processes to accelerate enrollment without compromising quality. When timelines are tight, we are ready to help sponsors and CROs move studies forward with confidence.

Rescue today. Results tomorrow. Let’s get your study back on course.

🔗 Ready to accelerate your study? Visit the link in our bio to learn more.

09/01/2026

CenExel is heading to the San Francisco Bay Area for the 20th Annual Pain Therapeutics Summit!

Representing CenExel will be:

• Todd Bertoch, MD | Chief Medical Officer, Pain Research
• Josh Rothstein, MD, MS, FACEP | Medical Director/Principal Investigator
• Carol Minoughan | Vice President, Business Development

Taking place September 28–29, the Pain Therapeutics Summit brings together leaders across biotech, pharma, academia, government, CROs, and the investment community to explore advances in pain therapeutics, translational research, clinical development, and non-opioid innovation.

Our team looks forward to connecting with sponsors, researchers, and industry partners to discuss innovative approaches to pain clinical trials and how CenExel’s scientific and operational expertise can help advance pain therapeutics from development through clinical research.

📅 September 28–29, 2026
📍 San Francisco Bay Area, CA

Attending the summit? Connect with Todd, Josh, and Carol while you’re there!

08/28/2026

Every study deserves a clear path forward. 🛟

When challenges arise, CenExel brings the enrollment capabilities, experienced teams, proven infrastructure, and nationwide reach needed to help studies regain momentum.

With 18 Centers of Excellence serving diverse metro communities, we are more than a site. We are a partner invested in your success.

Rescue today. Results tomorrow. Let’s get your study back on course.

🔗 Discover how CenExel can support your study through the link in our bio.

08/27/2026

CenExel is heading to Charlotte for the 79th To***co Science Research Conference (TSRC)! 🔬

George Hardie, MSc MRSB MICR, Senior Director, To***co Harm Reduction, and Hagar Wilkinson, Executive Site Director, will be attending September 20–23, joining researchers and industry colleagues from across the to***co science community.

George and Hagar look forward to connecting with colleagues, exchanging perspectives, and engaging in conversations around to***co science, harm reduction, and clinical research.

📅 September 20–23, 2026
📍 Sheraton Charlotte Hotel | Charlotte, NC

Attending ? Connect with George and Hagar while you’re there!

***coScience ***coHarmReduction

08/26/2026

Women deserve to feel seen, heard and supported throughout every stage of their health journey. 💙

On Women’s Equality Day, we recognize the importance of research that helps us better understand women’s health and experiences.

Clinical research is possible because people choose to participate. By volunteering, you may help researchers learn more and contribute to possibilities for future care.

Curious about clinical research? Visit the link in our bio to explore CenExel’s currently enrolling studies.

08/25/2026

CenExel is heading to Philadelphia for the ISCTM 2026 Autumn Conference, September 16–17!

We’re looking forward to joining leaders across CNS clinical research to exchange ideas on advancing clinical trial methodology. This year’s program will explore topics including biomarkers in neurology and psychiatry trials, digital health technologies, and innovative approaches to measuring outcomes in mood and psychosis research.

Representing CenExel at the conference will be:

• David Walling, PhD | Chief Scientific Director, Psychiatry
• Larry Ereshefsky, PharmD, BCPP | Chief Scientific Officer, Early Phase
• Elan Cohen, Ph.D. | Principal Investigator

If you’ll be at ISCTM, we’d welcome the opportunity to connect and discuss how CenExel’s scientific and clinical expertise can support the development of CNS therapies.

📍 Philadelphia, PA
📅 September 16–17, 2026

We hope to see you there!

08/21/2026

What does an anxiety clinical trial look like behind the scenes?

Dr. Saundra Maass-Robinson, Principal Investigator at CenExel Decatur, GA joined KTVU FOX 2’s Mornings on 2: The Nine to discuss an investigational treatment for generalized anxiety disorder and what participants can expect during an on-site dosing session.

From continuous support by a dosing session monitor to medical staff nearby, participant safety and support are central throughout the process. Dr. Saundra Maass-Robinson also discusses what comes next as research continues and additional data are gathered.

Interested in participating in clinical research? Tap the link in our bio to find a clinical trial near you.

Address

13907 Minuteman Drive #150
Draper, UT
84020

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm
Saturday	9am - 5pm
Sunday	9am - 5pm

Telephone

+18662363935

Website

https://cenexelresearch.com/

Alerts

Be the first to know and let us send you an email when CenExel posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Draper?